CD274 and neoplasm: Treatment with anti-PD-L1 monotherapy resulted in a substantially lower tumor mass compared to tumors treated with T-cell transfer alone, as well as increased depletion of PD-L1+ tumor cells, leukocytes, stromal and endothelial subpopulations within the tumor microenvironment at Day 21.